This finding was based on a 2018 study suggesting that CYP2C8 is an active driver of cancer after panel sequencing tumor samples from 273 patients with colorectal cancer (CRC) and an analysis of the somatic variants [85]. This evidence concerns the gene CYP2C8 and cancer.